FDA releases analysis on drug product quality in 2022
European Pharmaceutical Review
JULY 3, 2023
The Office of Pharmaceutical Quality (OPQ) in the US Food and Drug Administration (FDA)’s Center Pharmaceutical Quality for Drug Evaluation and Research (CDER) has released its 2022 annual report analysing drug manufacturers and their products. percent) to be noncompliant.
89 
Let's personalize your content